LifeMD, Inc.
For the period ended Mar 31, 2026. Filed May 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 6, 2026
LFMD$1.74-16.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity (Deficit)
Consolidated STATEMENTS of CHANGES IN STOCKHOLDERS’ EQUITY (Deficit)
| LifeMD, Inc. | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Series A Preferred Stock · Common Stock · Additional Paid-in · Accumulated · Treasury · Non-controlling Interest of Discontinued | ||||||||||
| Shares | Amount | Shares | Amount | Capital | Deficit | Stock | Total | Operations | Total | |
| Balance, January 1, 2025 | 1,400,000 | $140 | 42,293,907 | $422,939 | $230,508,339 | $(239,850,931) | $(163,701) | $(9,083,214) | $1,529,094 | $(7,554,120) |
| Stock compensation expense | - | - | 1,282,654 | 12,827 | 2,535,701 | - | - | 2,548,528 | - | 2,548,528 |
| Cashless exercise of stock options | - | - | 56,139 | 561 | (56) | - | - | - | - | - |
| Series A Preferred Stock Dividend | - | - | - | - | - | (776,563) | - | (776,563) | - | (776,563) |
| Distribution to non-controlling interest of discontinued operations | - | - | - | - | - | - | - | - | (36,000) | (36,000) |
| Net (loss) income | - | - | - | - | - | (183,778) | - | (183,778) | 531,845 | 348,067 |
| Balance, March 31, 2025 | 1,400,000 | $140 | 43,632,700 | $436,327 | $233,043,479 | $(240,811,272) | $(163,701) | $(7,495,027) | $2,024,939 | $(5,470,088) |
| Series A Preferred Stock · Common Stock · Additional Paid-in · Accumulated · Treasury | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Shares | Amount | Capital | Deficit | Stock | Total | |
| Balance, January 1, 2026 | 1,400,000 | $140 | 46,760,016 | $467,600 | $251,455,616 | $(228,603,075) | $(163,701) | $23,156,580 |
| Stock compensation expense | - | - | 819,691 | 8,197 | 1,440,708 | - | - | 1,448,905 |
| Exercise of stock options | - | - | 53,000 | 530 | 79,990 | - | - | 80,520 |
| Series A Preferred Stock Dividend | - | - | - | - | - | (776,563) | - | (776,563) |
| Net loss | - | - | - | - | - | (8,872,596) | - | (8,872,596) |
| Balance, March 31, 2026 | 1,400,000 | $140 | 47,632,707 | $476,327 | $252,976,314 | $(238,252,234) | $(163,701) | $15,036,846 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.